0
0

To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.

1/11/2023, 1:31 PM

Congressional Summary of HR 2433

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to describe the responsibilities of each agency center charged with reviewing drugs, medical devices, or biological products when reviewing a product that is a combination of drug, medical device, or biological product.

Current Status of Bill HR 2433

Bill HR 2433 is currently in the status of Bill Introduced since May 19, 2015. Bill HR 2433 was introduced during Congress 114 and was introduced to the House on May 19, 2015.  Bill HR 2433's most recent activity was Referred to the Subcommittee on Health. as of May 22, 2015

Bipartisan Support of Bill HR 2433

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2433

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)

Alternate Title(s) of Bill HR 2433

To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.
To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review.

Comments